Recent Update on the Role of Chinese Material Medica and Formulations in Diabetic Retinopathy
AbstractDiabetes mellitus is one of the most frequent endocrine disorders, affecting populations worldwide. Diabetic retinopathy (DR) is the most frequent microvascular complication of diabetes in patients aged 20 and over. Major complications of DR include intraocular neovascularization, inter-retinal edema, hemorrhage, exudates and microaneurysms. Therefore, timely medical attention and prevention are required. At present, laser-assisted therapy and other operational procedures are the most common treatment for DR. However, these treatments can cause retinal damage and scarring. Also, use of the majority of traditional medicines is not supported by clinical evidence. However, due to accumulating scientific evidence, traditional natural medications may assist in delaying or preventing the progression of DR. This review focuses on evidence for the role of traditional natural medicines and their mechanisms of action and pharmacological test results in relation to the progression of DR. View Full-Text
Share & Cite This Article
Vasant More, S.; Kim, I.-S.; Choi, D.-K. Recent Update on the Role of Chinese Material Medica and Formulations in Diabetic Retinopathy. Molecules 2017, 22, 76.
Vasant More S, Kim I-S, Choi D-K. Recent Update on the Role of Chinese Material Medica and Formulations in Diabetic Retinopathy. Molecules. 2017; 22(1):76.Chicago/Turabian Style
Vasant More, Sandeep; Kim, In-Su; Choi, Dong-Kug. 2017. "Recent Update on the Role of Chinese Material Medica and Formulations in Diabetic Retinopathy." Molecules 22, no. 1: 76.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.